r.malinowski
Submits third-party assay reports on material purchased directly. Based in Cali.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.95%
n=8
Suppliers covered
6
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043034 | Retatrutide | KP | KP-2607-H5219 | Janoshik | 2026-Q3 | 96.13 | 5.53 | 90.5 | Supplier-supplied | 2 | FAIL |
| AX-2026-042283 | Semaglutide | Homopeptide | HOMO-2604-M2254 | Janoshik | 2026-Q2 | 98.50 | 2.58 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041796 | BPC-157 | FGP | FGP-2512-A2448 | VendorInvestigate | 2026-Q1 | 99.19 | 3.55 | 106.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019547 | KPV | Homopeptide | HOMO-2411-P1141 | Janoshik | 2025-Q1 | 98.72 | 4.23 | 90.9 | Buyer-sourced | 0 | FAIL |
| AX-2024-004365 | Retatrutide | QSC | QSC-2411-C8332 | VendorInvestigate | 2024-Q4 | 98.35 | 4.05 | 98.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004589 | MK-677 (Ibutamoren mesylate) | JEEP | JEEP-2406-M4461 | Kestrel | 2024-Q4 | 99.91 | 5.15 | 104.8 | Laboratory-retained | 0 | FAIL |
| AX-2024-004573 | TB-500 | JEEP | JEEP-2407-K3892 | PeptideMeter | 2024-Q4 | 99.43 | 5.26 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005377 | Pinealon | CPC | CPC-2403-R3097 | Janoshik | 2024-Q2 | 99.34 | 7.93 | — | Supplier-supplied | 1 | FAIL |